Search This Blog

Monday, April 22, 2019

Rocket Pharmaceuticals initiated at Baird

Rocket Pharmaceuticals initiated with an Outperform at Baird. Baird analyst Madhu Kumar started Rocket Pharmaceuticals with an Outperform rating and $28 price target.
https://thefly.com/landingPageNews.php?id=2895331
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)